Working Together To Advance Prevention.
The miRoncol Real-time Multi-Cancer Early Risk Assessment is not only designed for individuals it’s also a valuable tool for healthcare providers, clinics, and organizations committed to proactive health. By partnering with miRoncol, you can bring real-time molecular insight into your programs, complementing conventional screening and physician-led care.
Why Partner with miRoncol?
Meaningful early insight
Adds molecular-level risk awareness to preventive care.
Proven Studies
Solid science with specificity above 99% and strong sensitivity across many common cancers.
Flexible integration
Can be included in annual checkups, executive health packages, or integrative wellness programs.
Ethical foundation
Designed to complement, not replace, conventional diagnostics and physician judgment.
Who We Work With
Family Doctors & Integrative Medicine Practitioners
Support patients who want proactive cancer risk assessment beyond routine panels.
Executive Health Clinics
Offer discerning clients molecular insights that complement MRI, genomics, and longevity programs.
Wellness & Naturopathic Clinics
Incorporate molecular signals into preventive and lifestyle-focused care.
Health Coaches & Influencers
Use science-backed tools to motivate evidence-informed wellness strategies.
Longevity Clinics
Add real-time molecular risk assessment to programs focused on aging and prevention.
Foundations & Non-Profits
Collaborate on awareness, education, and equity in early detection.
Benefits of Partnership
- Enhance preventive care offerings with cutting-edge molecular science
- Support patients and clients with peace of mind and clarity
- Stay at the forefront of cancer prevention innovation
- Access resources, reports, and guidance for ethical use
Next Step
miRoncol partnerships are built on trust, scientific rigor, and a shared commitment to prevention. Together, we can make meaningful early detection more accessible.
